These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33402250)
1. [Perioperative treatment for resected non-small cell lung cancer: Which option in 2020?]. Coureau M; Berghmans T Rev Mal Respir; 2021 Jan; 38(1):74-86. PubMed ID: 33402250 [TBL] [Abstract][Full Text] [Related]
3. [Current knowledge on perioperative treatments of non-small cell lung carcinomas]. Brosseau S; Naltet C; Nguenang M; Gounant V; Mordant P; Milleron B; Castier Y; Zalcman G Rev Mal Respir; 2017 Jun; 34(6):618-634. PubMed ID: 28709816 [TBL] [Abstract][Full Text] [Related]
4. [Is there a place for surgical management in stage IIIA N2 non-small cell lung cancer?]. Pagès PB; Pforr A; Delpy JP; Abou Hanna H; Bernard A Rev Mal Respir; 2015 May; 32(5):485-92. PubMed ID: 25498767 [TBL] [Abstract][Full Text] [Related]
7. Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages. Scagliotti G Lung Cancer; 2002 Dec; 38 Suppl 3():S23-9. PubMed ID: 12468140 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759 [TBL] [Abstract][Full Text] [Related]
9. [Ipilimumab-nivolumab as first-line treatment in metastatic NSCLC]. El-Ghazzi N; Lavaud P Bull Cancer; 2021 Mar; 108(3):231-233. PubMed ID: 33622569 [No Abstract] [Full Text] [Related]
10. Referral patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. Kassam F; Shepherd FA; Johnston M; Visbal A; Feld R; Darling G; Keshavjee S; Pierre A; Waddell T; Leighl NB J Thorac Oncol; 2007 Jan; 2(1):39-43. PubMed ID: 17410008 [TBL] [Abstract][Full Text] [Related]
11. Role of surgery in a novel multimodal therapeutic approach to complete cure of advanced lung cancer: current and future perspectives. Yamane M; Toyooka S Surg Today; 2022 Jan; 52(1):1-11. PubMed ID: 33738585 [TBL] [Abstract][Full Text] [Related]
12. Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial). Kocher F; Pircher A; Mohn-Staudner A; Romeder F; Duller W; Steinmaurer M; Eckmayr J; Schmid T; Hilbe W; Fiegl M; Greil R Lung Cancer; 2014 Sep; 85(3):395-400. PubMed ID: 25043642 [TBL] [Abstract][Full Text] [Related]
13. Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer. Nagasaka M; Gadgeel SM Expert Rev Anticancer Ther; 2018 Jan; 18(1):63-70. PubMed ID: 29168933 [TBL] [Abstract][Full Text] [Related]
14. Should adjuvant chemotherapy become standard treatment in all patients with resected non-small-cell lung cancer? Le Chevalier T; Arriagada R; Pignon JP; Scagliotti GV Lancet Oncol; 2005 Mar; 6(3):182-4. PubMed ID: 15759364 [TBL] [Abstract][Full Text] [Related]
15. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)]. Nakajima E; Katou H Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265 [TBL] [Abstract][Full Text] [Related]
16. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA; Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766 [TBL] [Abstract][Full Text] [Related]
17. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ; J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710 [TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant chemotherapy and radiotherapy for stage II and III non-small cell lung cancer (NSCLC). Lee SW; Choi EK; Chung WK; Shin KH; Ahn SD; Kim JH; Kim SW; Suh C; Lee JS; Kim WS; Kim DS; Kim DK; Park SI; Sohn KH Lung Cancer; 2002 Jul; 37(1):65-71. PubMed ID: 12057869 [TBL] [Abstract][Full Text] [Related]
19. [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. European Lung Cancer Working Party Rev Med Brux; 2006; 27(1):29-38. PubMed ID: 16608009 [TBL] [Abstract][Full Text] [Related]
20. Systemic and targeted therapies for early-stage lung cancer. Byron E; Pinder-Schenck M Cancer Control; 2014 Jan; 21(1):21-31. PubMed ID: 24357738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]